Skip to main content
CRS 2025 Annual Meeting & Exposition Main banner

Nanomedicine and Nanoscale Delivery

Tech Session IV: Nanomedicine and Nanoscale Delivery (Focus: Nano)

A designer transcytotic Paclitaxel nanovesicle for TNBC and pancreatic cancer combination therapies

Wednesday, July 16, 2025
3:27 PM – 3:38 PM EDT

Learning Objectives:

At the completion of this activity, participants will know
  • Describe the development and advantages of sphingomyelin-derived nanovesicle drug delivery systems.
  • Demonstrate tumor delivery mechanisms using pH-sensitive and CD47-functionalized nanocarriers.
  • List strategies to improve paclitaxel pharmacokinetics and tumor targeting in nanotherapeutics.

    Oral Abstract Speaker(s)

  • Jianqin Lu, PhD

    John A. and Frances P. Ware Associate Professor
    University of Arizona
    TUCSON, Arizona, United States